Literature DB >> 30177216

Lack of Association Between Anemia and Intrinsic Left Ventricular Diastolic Function or Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction.

Jacob A Burns1, Cynthia Sanchez1, Lauren Beussink1, Vistasp Daruwalla1, Benjamin H Freed1, Senthil Selvaraj1, Sanjiv J Shah2.   

Abstract

Anemia is associated with a poor prognosis in heart failure with preserved ejection fraction (HFpEF), but the reasons underlying this association are unclear. Previous studies have reported an association between anemia and diastolic dysfunction. However, these studies used volume- and flow-dependent indexes of diastolic dysfunction. We hypothesized that in HFpEF, anemia is more closely associated with volume status and not markers of intrinsic myocardial dysfunction. We prospectively studied 419 outpatients in a systematic HFpEF program, all of whom underwent hemoglobin measurement and comprehensive echocardiography. Longitudinal, radial, and circumferential strain were also measured in 311 patients. We defined anemia as hemoglobin <12g/dL in women and <13g/dL in men. Linear and Cox regression analyses were used to determine the association between anemia and echocardiographic/strain variables and adverse outcomes, respectively. Over half (224/419 [53%]) of the HFpEF patients had anemia. Anemia was associated with volume (preload)-dependent markers of diastolic dysfunction including echocardiographic E/A (p = 0.004) and E/e' ratio (p = 0.014) and elevated right heart pressures such as right atrial pressure (p = 0.002) and pulmonary artery systolic pressure (p<0.001). Anemia was not associated with markers of intrinsic myocardial dysfunction such as lateral e' (p = 0.16) and septal e' (p = 0.65) velocities or echocardiographic strain parameters (p > 0.05 for all comparisons). Anemia was associated with the combined outcome of cardiovascular hospitalization or death (hazard ratio = 1.50 [95% confidence interval 1.20, 1.88]; p < 0.001). In conclusion, anemia in HFpEF is associated with markers of volume status and not intrinsic markers of myocardial dysfunction.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30177216      PMCID: PMC6195843          DOI: 10.1016/j.amjcard.2018.06.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Preload dependence of new Doppler techniques limits their utility for left ventricular diastolic function assessment in hemodialysis patients.

Authors:  Eric H Y Ie; Wim B Vletter; Folkert J ten Cate; Robert W Nette; Willem Weimar; Jos R T C Roelandt; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

2.  Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.

Authors:  Michael R Zile; John S Gottdiener; Scott J Hetzel; John J McMurray; Michel Komajda; Robert McKelvie; Catalin F Baicu; Barry M Massie; Peter E Carson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

Review 3.  Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Circulation       Date:  2006-05-23       Impact factor: 29.690

4.  Diastolic dysfunction is associated with anaemia in patients with Type II diabetes.

Authors:  Piyush M Srivastava; Merlin C Thomas; Paul Calafiore; Richard J MacIsaac; George Jerums; Louise M Burrell
Journal:  Clin Sci (Lond)       Date:  2006-01       Impact factor: 6.124

Review 5.  Prevalence of anemia and effects on mortality in patients with heart failure.

Authors:  Joann Lindenfeld
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

6.  Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.

Authors:  Erin D Unger; Ruth F Dubin; Rajat Deo; Vistasp Daruwalla; Julie L Friedman; Crystal Medina; Lauren Beussink; Benjamin H Freed; Sanjiv J Shah
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

7.  Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.

Authors:  Eileen O'Meara; Tim Clayton; Margaret B McEntegart; John J V McMurray; Chim C Lang; Simon D Roger; James B Young; Scott D Solomon; Christopher B Granger; Jan Ostergren; Bertil Olofsson; Eric L Michelson; Stuart Pocock; Salim Yusuf; Karl Swedberg; Marc A Pfeffer
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

8.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

9.  Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

Authors:  C P Appleton; L K Hatle; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

10.  Echocardiographic estimation of pulmonary capillary wedge pressure using the combination of diastolic annular and mitral inflow velocities.

Authors:  Tadafumi Sugimoto; Kaoru Dohi; Masaki Tanabe; Kiyotaka Watanabe; Emiyo Sugiura; Shiro Nakamori; Tomomi Yamada; Katsuya Onishi; Mashio Nakamura; Tsutomu Nobori; Masaaki Ito
Journal:  J Echocardiogr       Date:  2012-08-23
View more
  2 in total

1.  Clinical, Demographic, and Imaging Correlates of Anemia in Heart Failure With Preserved Ejection Fraction (from the RELAX Trial).

Authors:  Vibhu Parcha; Nirav Patel; Rajat Kalra; Anirudh Bhargava; Sumanth D Prabhu; Garima Arora; Pankaj Arora
Journal:  Am J Cardiol       Date:  2020-03-16       Impact factor: 2.778

Review 2.  Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis.

Authors:  Xuanyi Jin; Jan F Nauta; Chung-Lieh Hung; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Adriaan A Voors; Carolyn Sp Lam; Joost P van Melle
Journal:  Heart Fail Rev       Date:  2022-01-26       Impact factor: 4.654

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.